XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
1.850
+0.120 (6.94%)
Jan 22, 2025, 4:00 PM EST - Market closed
XTL Biopharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jan '25 Jan 22, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 16 | 5 | 6 | 15 | 16 | 7 | |
| Market Cap Growth | 490.49% | -16.65% | -57.56% | -4.50% | 124.03% | -26.14% | |
| Enterprise Value | 14 | 3 | 2 | 12 | 12 | 2 | |
| Last Close Price | 1.81 | 1.01 | 1.21 | 2.77 | 3.03 | 1.37 | |
| PE Ratio | - | - | - | 34.41 | - | - | |
| PB Ratio | 5.31 | 2.39 | 1.59 | 2.81 | 4.34 | 1.07 | |
| P/TBV Ratio | - | 2.88 | 1.76 | 3.02 | 4.85 | 1.14 | |
| Quick Ratio | 0.75 | 9.74 | 19.90 | 26.52 | 23.79 | 29.00 | |
| Current Ratio | 0.81 | 9.93 | 20.35 | 27.00 | 24.10 | 29.44 | |
| Return on Equity (ROE) | -25.70% | -57.31% | -28.89% | 9.73% | -58.34% | -11.07% | |
| Return on Assets (ROA) | -16.33% | -14.46% | -10.18% | -9.82% | -8.64% | -6.67% | |
| Return on Capital (ROIC) | -23.73% | -15.38% | -11.79% | -14.41% | -11.70% | -7.63% | |
| Earnings Yield | -6.76% | -33.65% | -21.22% | 2.91% | -18.85% | -10.90% | |
| FCF Yield | -13.35% | -14.18% | -7.01% | -5.43% | -13.01% | |
| Buyback Yield / Dilution | -7.97% | 0.00% | 11.48% | -19.71% | - | - | |
| Total Shareholder Return | -7.97% | 0.00% | 11.48% | -19.71% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.